1. Phase II study of pegylated liposomal doxorubicin, low‐dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma. Issue 1 (January 2014) Authors: Baz, Rachid C.; Shain, Kenneth H.; Hussein, Mohamad A.; Lee, Ji‐Hyun; Sullivan, Daniel M.; Oliver, Elizabeth Finley; Nardelli, Lisa A.; Nodzon, Lisa A.; Zhao, Xiuhua; Ochoa‐Bayona, Jose Leonel; Nishihori, Taiga; Dalton, William S.; Alsina, Melissa Journal: American journal of hematology Issue: Volume 89:Issue 1(2014:Jan.) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗